{"count": 5, "results": [{"_id": "37209947", "pmid": 37209947, "title": "Metabolic Complications of Glucocorticoids - Prevention by Metformin.", "journal": "Ann Endocrinol (Paris)", "authors": ["Sanpawithayakul K", "Korbonits M"], "date": "2023-05-18T00:00:00Z", "doi": "10.1016/j.ando.2023.05.002", "meta_date_publication": "2023 May 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50295.617, "text_hl": "@<m>DISEASE_Brain_Diseases_Metabolic_Inborn</m> @DISEASE_MESH:D020739 @@@Metabolic Complications@@@ of Glucocorticoids - Prevention by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@.", "citations": {"NLM": "Sanpawithayakul K, Korbonits M. Metabolic Complications of Glucocorticoids - Prevention by Metformin. Ann Endocrinol (Paris). 2023 May 18;():. PMID: 37209947", "BibTeX": "@article{37209947, title={Metabolic Complications of Glucocorticoids - Prevention by Metformin.}, author={Sanpawithayakul K and Korbonits M}, journal={Ann Endocrinol (Paris)}}"}}, {"_id": "32109422", "pmid": 32109422, "title": "Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.", "journal": "Lancet Diabetes Endocrinol", "authors": ["Pernicova I", "Kelly S", "Ajodha S", "Sahdev A", "Bestwick JP", "Gabrovska P", "Akanle O", "Ajjan R", "Kola B", "Stadler M", "Fraser W", "Christ-Crain M", "Grossman AB", "Pitzalis C", "Korbonits M"], "date": "2020-04-01T00:00:00Z", "doi": "10.1016/S2213-8587(20)30021-8", "meta_date_publication": "2020 Apr", "meta_volume": "8", "meta_issue": "4", "meta_pages": "278-291", "score": 50262.973, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ to reduce @<m>DISEASE_Brain_Diseases_Metabolic_Inborn</m> @DISEASE_MESH:D020739 @@@metabolic complications@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in @SPECIES_9606 @@@patients@@@ on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.", "citations": {"NLM": "Pernicova I, Kelly S, Ajodha S, Sahdev A, Bestwick JP, Gabrovska P, Akanle O, Ajjan R, Kola B, Stadler M, Fraser W, Christ-Crain M, Grossman AB, Pitzalis C, Korbonits M. Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial. Lancet Diabetes Endocrinol. 2020 Apr;8(4):278-291. PMID: 32109422", "BibTeX": "@article{32109422, title={Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.}, author={Pernicova I and Kelly S and Ajodha S and Sahdev A and Bestwick JP and Gabrovska P and Akanle O and Ajjan R and Kola B and Stadler M and Fraser W and Christ-Crain M and Grossman AB and Pitzalis C and Korbonits M}, journal={Lancet Diabetes Endocrinol}, volume={8}, number={4}, pages={278-291}}"}}, {"_id": "36768561", "pmid": 36768561, "pmcid": "PMC9917329", "title": "Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target", "journal": "Int J Mol Sci", "authors": ["Ziqubu K", "Mazibuko-Mbeje SE", "Mthembu SXH", "Mabhida SE", "Jack BU", "Nyambuya TM", "Nkambule BB", "Basson AK", "Tiano L", "Dludla PV"], "date": "2023-01-23T00:00:00Z", "doi": "10.3390/ijms24032227", "meta_date_publication": "2023 Jan 23", "meta_volume": "24", "meta_issue": "3", "meta_pages": "", "score": 50257.64, "text_hl": "There is a general interest in understanding the pleiotropic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @<m>DISEASE_Brain_Diseases_Metabolic_Inborn</m> @DISEASE_MESH:D020739 @@@metabolic complications@@@. ", "citations": {"NLM": "Ziqubu K, Mazibuko-Mbeje SE, Mthembu SXH, Mabhida SE, Jack BU, Nyambuya TM, Nkambule BB, Basson AK, Tiano L, Dludla PV. Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target Int J Mol Sci. 2023 Jan 23;24(3):. PMID: 36768561", "BibTeX": "@article{36768561, title={Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target}, author={Ziqubu K and Mazibuko-Mbeje SE and Mthembu SXH and Mabhida SE and Jack BU and Nyambuya TM and Nkambule BB and Basson AK and Tiano L and Dludla PV}, journal={Int J Mol Sci}, volume={24}, number={3}}"}}, {"_id": "39338363", "pmid": 39338363, "title": "Bixin Combined with Metformin Ameliorates Insulin Resistance and Antioxidant Defenses in Obese Mice.", "journal": "Pharmaceuticals (Basel)", "authors": ["Pinheiro CG", "Motta BP", "Oliveira JO", "Cardoso FN", "Figueiredo ID", "Machado RTA", "da Silva PB", "Chorilli M", "Brunetti IL", "Baviera AM"], "date": "2024-09-12T00:00:00Z", "doi": "10.3390/ph17091202", "meta_date_publication": "2024 Sep 12", "meta_volume": "17", "meta_issue": "9", "meta_pages": "", "score": 50250.1, "text_hl": "@CHEMICAL_bixin @CHEMICAL_MESH:C004588 @@@Bixin@@@ combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improved the endogenous antioxidant defenses in the @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_10090 @@@mice@@@, showing that this combined therapy may have the potential to contrast the @<m>DISEASE_Brain_Diseases_Metabolic_Inborn</m> @DISEASE_MESH:D020739 @@@metabolic complications@@@ resulting from oxidative stress.", "citations": {"NLM": "Pinheiro CG, Motta BP, Oliveira JO, Cardoso FN, Figueiredo ID, Machado RTA, da Silva PB, Chorilli M, Brunetti IL, Baviera AM. Bixin Combined with Metformin Ameliorates Insulin Resistance and Antioxidant Defenses in Obese Mice. Pharmaceuticals (Basel). 2024 Sep 12;17(9):. PMID: 39338363", "BibTeX": "@article{39338363, title={Bixin Combined with Metformin Ameliorates Insulin Resistance and Antioxidant Defenses in Obese Mice.}, author={Pinheiro CG and Motta BP and Oliveira JO and Cardoso FN and Figueiredo ID and Machado RTA and da Silva PB and Chorilli M and Brunetti IL and Baviera AM}, journal={Pharmaceuticals (Basel)}, volume={17}, number={9}}"}}, {"_id": "28073907", "pmid": 28073907, "title": "Metformin prevents metabolic side effects during systemic glucocorticoid treatment.", "journal": "Eur J Endocrinol", "authors": ["Seelig E", "Meyer S", "Timper K", "Nigro N", "Bally M", "Pernicova I", "Schuetz P", "Müller B", "Korbonits M", "Christ-Crain M"], "date": "2017-03-01T00:00:00Z", "doi": "10.1530/EJE-16-0653", "meta_date_publication": "2017 Mar", "meta_volume": "176", "meta_issue": "3", "meta_pages": "349-358", "score": 50063.684, "text_hl": "CONCLUSIONS: In this first randomised controlled trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ targeting @<m>DISEASE_Brain_Diseases_Metabolic_Inborn</m> @DISEASE_MESH:D020739 @@@metabolic complications@@@ in @SPECIES_9606 @@@patients@@@ needing glucocorticoid therapy, we observed a beneficial effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on glycaemic control. ", "citations": {"NLM": "Seelig E, Meyer S, Timper K, Nigro N, Bally M, Pernicova I, Schuetz P, Müller B, Korbonits M, Christ-Crain M. Metformin prevents metabolic side effects during systemic glucocorticoid treatment. Eur J Endocrinol. 2017 Mar;176(3):349-358. PMID: 28073907", "BibTeX": "@article{28073907, title={Metformin prevents metabolic side effects during systemic glucocorticoid treatment.}, author={Seelig E and Meyer S and Timper K and Nigro N and Bally M and Pernicova I and Schuetz P and Müller B and Korbonits M and Christ-Crain M}, journal={Eur J Endocrinol}, volume={176}, number={3}, pages={349-358}}"}}]}